Efficacy and Safety of the Selective, Brain-Penetrant P2X7 Receptor Antagonist JNJ-55308942 (Zanvipixant) in Bipolar Depression: A Phase 2a Study. [PDF]
Palmer JA +10 more
europepmc +1 more source
Activity of Peptides Modulating the Action of p2x Receptors: Focus on the p2x7 Receptor. [PDF]
De Souza Oliveira Carneiro JA +3 more
europepmc +1 more source
Therapeutic potential of P2X7 receptor in retinal diseases. [PDF]
Wen M +6 more
europepmc +1 more source
A Holistic Approach to Identifying a Positron Emission Tomography (PET) Tracer Candidate for In Vivo Imaging of Purinergic P2X7 Receptor in Neuroinflammation. [PDF]
Ghafir El Idrissi I +23 more
europepmc +1 more source
Targeting the P2X7 receptor in cerebrovascular diseases: from molecular mechanisms to preclinical therapeutic potential. [PDF]
Hu Z +5 more
europepmc +1 more source
Bionic Nanoparticle Hydrogel for Astrocyte-Targeted Estradiol Delivery Ameliorates Perimenopausal Depression via P2X7 Receptor Inhibition. [PDF]
Chu K +9 more
europepmc +1 more source
Trends in Research on the P2X7 Receptor: A Bibliometric and Visualization Analysis. [PDF]
Ren C +8 more
europepmc +1 more source
Type II Cells in the Human Carotid Body Display P2X7 Receptor and Pannexin-1 Immunoreactivity. [PDF]
Anache M +10 more
europepmc +1 more source
Blockage of P2X7 receptor activation attenuated bone loss in ligature-induced model of periodontitis in rats. [PDF]
Linhares N +14 more
europepmc +1 more source
Increased levels of GFAP and purinergic P2X7 receptor in Alzheimer's disease brain are associated with Aβ, tau pathologies and synaptic loss. [PDF]
Maschio CA +12 more
europepmc +1 more source

